Articles tagged with “gxp-compliance”

Compare Microsoft 365 and Google Workspace for pharmaceutical GxP compliance. Learn how each cloud platform meets FDA 21 CFR Part 11 and data integrity rules.

Review regulatory requirements for assembling pharma AI validation evidence packages. Examine FDA and EMA guidelines, credibility frameworks, and GxP rules.

Explore how pharmaceutical companies use low-code platforms to build GxP-compliant MES and QMS applications while meeting strict 21 CFR Part 11 standards.

Explore SAP S/4HANA implementation in pharmaceutical manufacturing. This guide details GxP compliance, module selection, and computer system validation.

Analyze leading GxP compliance software, eQMS, and document management platforms for life sciences. Learn how systems meet 21 CFR Part 11 and ALCOA+ rules.

Understand the architecture of GxP-compliant data pipelines for pharma AI. This report analyzes data engineering frameworks using Databricks and Snowflake.

Learn how to deploy ChatGPT Enterprise in regulated GxP environments. This guide covers FDA compliance, 21 CFR Part 11, system validation, and data integrity.

Examine how AI automates GxP evidence packages and compliance workflows. Review regulatory frameworks, ALCOA+ data integrity, and AI system validation methods.

Examine the pharmaceutical AI strategy roadmap for scaling digital transformation. Learn about enterprise data infrastructure, LLMOps, and GxP compliance.

Review how pharma data engineering workshops train teams in Databricks and AI. Examine Lakehouse architecture, GxP compliance, and workforce skills development.

An analysis of AI governance in pharmacovigilance, detailing how the EU AI Act and GxP regulations impact drug safety platforms like Oracle Argus and Veeva.

Analyze FDA Project Elsa, a generative AI system that prioritizes facility inspections by detecting risk patterns in adverse events and regulatory data.

Learn to validate AI vendor claims in pharma. This due diligence checklist covers GxP compliance, data security, and model performance verification methods.

Examine evidence for open-source software in GxP environments. Learn how validation strategies enable compliance while eliminating proprietary vendor lock-in.

Review the ISPE GAMP AI Guide for validating machine learning in GxP. Learn the risk-based framework for data integrity and regulatory compliance.

Explore AI governance frameworks for pharmaceutical companies. Learn to align AI with GxP, FDA regulations, and data integrity standards for safe adoption.

Explore GxP requirements for Electronic Batch Records (EBR) in biotech. Covers FDA 21 CFR Part 11 compliance, validation, and current software options.

Analyze the transition from CSV to FDA's Computer Software Assurance (CSA). This guide details risk-based validation strategies and compliance impacts.

Explore GxP audit trail requirements for AI systems. Review 21 CFR Part 11, Annex 11, and ALCOA+ rules for logging training data, prompts, and model outputs.

Explore GxP compliance requirements for ChatGPT and Copilot. Learn about 21 CFR Part 11, system validation, and data integrity strategies for regulated AI.

Learn AI/ML validation in GxP using GAMP 5 2nd Ed. and FDA CSA. Explains risk-based lifecycles, data integrity, and compliance for adaptive models.

Explore the Veeva Vault platform for life sciences. Learn about its cloud architecture, GxP compliance features, and applications like Quality, eTMF, and RIM.

Explore cloud-based regulatory submission tools for pharma. This guide covers eCTD software, RIM systems, compliance (21 CFR Part 11), benefits, and challenges.

Compare SaaS vs. on-premise eCTD solutions for pharma. This guide analyzes TCO, scalability, GxP compliance (21 CFR Part 11), and security for both models.

Learn to implement an audit-ready ISO 27001 ISMS for life sciences. This guide covers integrating cybersecurity with GxP, QMS, and FDA regulatory compliance.

Choosing a GxP ELN? Compare Benchling, IDBS, and LabArchives on features for 21 CFR Part 11 compliance, system validation, and ALCOA data integrity principles.

Learn to validate AI/ML systems in GxP manufacturing using the GAMP 5 Appendix D11 framework. Explore key considerations for data integrity, risk, and model dri

Learn to deploy private LLMs in pharma. This guide covers compliant architecture, including on-premise & cloud, and navigating HIPAA, GxP, and FDA regulations.

Learn to apply the GAMP 5 risk-based approach for AI/ML validation in GxP environments. This guide covers data integrity, model drift, and regulatory compliance

Understand the FDA's final Computer Software Assurance (CSA) guidance, a risk-based shift from CSV for pharma & biotech. Learn key principles for compliance.

Learn how to integrate GAMP 5 (2nd Ed.) and FDA's final Computer Software Assurance (CSA) guidance (Sept 2025, updated Feb 2026). Shift from CSV to risk-based validation.

Updated April 2026 for ServiceNow's Yokohama and Zurich releases, the Moveworks acquisition, and new FDA/EMA AI guidance. A guide to ServiceNow use cases in healthcare and life sciences – ITSM for clinical workflows, patient experience, HIPAA/GxP compliance, EMR integration, and agentic AI.

Learn how generative AI and LLMs assist in drafting pharma IND & CTA submissions. This guide covers benefits, risks, GxP compliance, FDA/EMA 2026 joint AI principles, and tools like AutoIND and Narrativa.

Learn about clinical trial vendor management and how CROs ensure oversight of labs, logistics, and translation services per ICH E6(R3) GCP and regulatory standards. Updated for 2026 with the latest on ICH E6(R3) implementation, decentralized trial logistics, and AI-assisted translation.

Explore how AI impacts Good Documentation Practice (GDocP) and ALCOA+ principles in life sciences. Updated with the 2026 joint FDA-EMA 10 Guiding Principles, EU AI Act implementation timeline, and the EMA's first AI qualification opinion. Learn about efficiency gains, data integrity risks, and regulatory compliance strategies.

Updated 2026 guide to pharmaceutical compliance software for GxP and QMS. Compare Veeva, MasterControl, ETQ & more with FDA QMSR, CSA guidance, and Gartner MQ coverage

Learn key principles for custom pharmaceutical software app design. Updated for 2026 with FDA CSA guidance, GAMP 5 Second Edition, GxP compliance, 21 CFR Part 11, and AI/ML trends

A detailed 2025 analysis of the GxP managed services market for pharma & life sciences. Learn about trends, regulatory drivers, and GxP compliance challenges.

Learn about Dassault Systèmes' QUMAS EDMS for life sciences. This guide covers its features, EDMS 2026 release, AI integration, and use cases for GxP and 21 CFR Part 11 compliance.

Compare Veeva vs Salesforce for life sciences CRM (updated Feb 2026). Covers Vault CRM migration, Agentforce Life Sciences, AI agents, the Informatica acquisition, and the 2030 platform decoupling deadline.

Learn the key updates in ISPE GAMP 5 Second Edition. Updated for 2026 with FDA's finalized CSA guidance, ISPE GAMP AI Guide, and EU Annex 11/22 revisions

A comprehensive guide to Veeva Vault's 2025 platform updates. Learn about key features in 25R1, 25R2, & 25R3, including Action Triggers, Process Monitor & Veeva

An explanation of regulatory requirements for audit trails under 21 CFR Part 11 and EU Annex 11, covering automation strategies, data integrity measures, and the latest 2025-2026 regulatory developments including the Annex 11 draft revision and FDA CSA guidance.

A comprehensive guide to implementing and optimizing NetSuite ERP for pharmaceutical companies, covering supply chain management, manufacturing operations, quality control, regulatory compliance, and integration with specialized pharma systems.